Nanox To Acquire VasoHealthcare IT From Vaso For Total Consideration Of Up To $800K

NANO-X IMAGING LTD (("Nanox" or the "Company", NASDAQ:NNOX), an innovative medical imaging technology company, today announced that the parties have agreed on the terms and conditions pursuant to which Nanox will acquire VasoHealthcare IT Inc. ("VHC IT") from Vaso Corporation ("Vaso") (OTCQX:VASO), subject to certain conditions.

This transaction is intended to accelerate deployment of Nanox's AI solutions across U.S. healthcare facilities and is expected to be executed and completed within a couple of weeks.

Under the terms of the proposed acquisition, VHC IT's established operational and customer-support infrastructure will be integrated with Nanox.AI's FDA-cleared AI solutions that analyze routine CT scans for indicators of chronic diseases. This integration, once completed, will enable faster deployment and adoption while reducing time-to-value for healthcare providers. VHC IT team's, expertise and long-standing customer relationships are expected to support the Company's U.S. commercial expansion.

Under the terms of the proposed transaction, Nanox will acquire VHC IT for a total consideration of up to $800,000, consisting of a $200,000 cash payment at closing and up to $600,000 in performance-based earnout payments over a period of up to two years, contingent upon revenue retention targets with respect to existing customers.